Xenon's lead asset, azetukalner, shows promise in treating focal onset seizures with positive phase IIb results and upcoming ...

Partnership bolsters Boehringer's autoimmune and inflammatory disease pipeline portfolio aiming to tackle areas of high unmet ...

St George’s Hospital in Tooting, London, and Morriston Hospital in Swansea, Wales, became the first two hospitals in the UK ...

INFINOX is a globally regulated FX and CFD broker. It was launched in 2009, and its services are available in 15 countries. Three licenses confirm its integrity ...

Steve brings deep experience in strategic transactions to Werewolf at this critical time,” said Daniel J. Hicklin, Ph.D., President and Chief Executive Officer of Werewolf Therapeutics. “Werewolf is ...

Emerge is the first Phase 3 study of lysergide D-tartrate (LSD) in MDD; primary endpoint will measure change from baseline in Montgomery-Åsberg Depression Rating Scale (MADRS) score at Week 6 between ...

Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a commercial-stage company focused on providing therapies for people living with rare disease, today announces the publication of ...

Catalent to evaluate certepetide with its SMARTag® antibody-drug conjugate platformBASKING RIDGE, N.J., April 15, 2025 (GLOBE NEWSWIRE) -- ...

UK HealthCare made a dramatic, stirring ad about a young climber who said her cancer was cured by UK doctors. But the ad did not disclose that she was an actor, not a patient.

An Oklahoma House committee will investigate ODMHSAS issues, and controversial Tulsa County contracts have been pulled amid ...

Canada’s future is not doom and gloom Re: “This is not a time for magical thinking,” commentary, April 19. Re: “This is not a ...

Morgan Stanley chairman Jonathan Bloomer, his wife Judith Bloomer, Clifford Chance lawyer Christopher Morvillo and his wife ...